Among them, especially for ovarian cancer, CMTM3/4/6/7/8 had a relatively high expression in ovarian cancer compared to control normal tissues, while CMTM1/2/5 had a relatively low expression. This evidence concerns the gene CMTM1 and ovarian carcinoma.